Prepaire™ Labs and Ncardia announced the signing of a 5-year agreement. The potential outcome of this partnership will accelerate aspects of drug discovery and development, including target discovery, lead optimization, toxicity assessment, and trial design.
[Prepaire (EIN Presswire)]
